Rankings
▼
Calendar
OCGN Q3 2019 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$710M
Q3 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$3M
Net Income
-$23M
EPS (Diluted)
$-3.55
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$3M
Free Cash Flow
$3M
Stock-Based Comp.
$576,014
Balance Sheet
Total Assets
$24M
Total Liabilities
$37M
Stockholders' Equity
-$13M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$3M
-$7M
+61.2%
Net Income
-$23M
$11M
-313.8%
← FY 2019
All Quarters
Q4 2019 →